New diagnostic tool could revolutionize early bladder cancer detection

Less than a year in­to a rocky roll­out for its gene ther­a­py Roc­ta­vian, Bio­Marin is now talk­ing about whether the prod­uct might be a bet­ter

An FDA advisory committee will consider whether PD-L1 expression cutoffs should guide use of checkpoint inhibitors to treat advanced gastroesophageal cancers. Current approved indications for